Novogen Limited

Press Releases

2013-December-20	Novogen Announces Establishment of Global Collaboration (in PDF)
2013-December-19	Novogen to Present at Biotech Showcase in San Francisco (in PDF)
2013-November-26	Novogen Files Patents for Anti-tropomyosin Drug Technology (in PDF)
2013-November-25	Trilexium Destroys Ovarian Cancer Stem Cell Spheroids (in PDF)
2013-November-15	Issue of Convertible Note (in PDF)
2013-November-14	Novogen Announces Important Discovery (in PDF)
2013-November-7	Press Release Relative to New Joint Venture (in PDF)
2013-November-7	Novogen Announces Joint Venture (in PDF)
2013-October-9	New Technology to Add to Oncology Drug Pipeline (in PDF)
2013-August-7	Appointment of Chairman of Medical Advisory Board (in PDF)
2013-July-4	Funding Arrangement (in PDF)
2013-June-27	Explanatory Notice for Shareholders Who Hold Stock in MEIP (in PDF)
2013-May-29	Novogen CEO to Speak at Investor Forum (in PDF)
2013-May-29	Novogen Announces SPP Outcome (in PDF)
2013-May-29	Results of Share Purchase Plan (in PDF)
2013-May-10	Extension of Share Purchase Plan (in PDF)
2013-May-7	Novogen Oncology Discovery Library and Indications Expand (in PDF)
2013-May-7	Novogen Announces New Executive Appointments (in PDF)
2013-May-7	Change of Registered Office (in PDF)
2013-April-19	Novogen Director Steps Down (in PDF)
2013-April-17	Novogen Releases Newsletter to Coincide with General Meeting (in PDF)
2013-April-12	Novogen Announces Placement of Stock to Raise $2.5M (in PDF)
2013-April-8	Successful Isolation of Most Potent Form of CS-6 (in PDF)
2013-April-3	Potency of CS-6 Confirmed (in PDF)
2013-March-6	MOU Signed with The Ingham Institute (in PDF)
2013-February-21	Novogen Demerger Tax Implications (in PDF)
2013-February-18	CS-6 Highly Active Against Ovarian Cancer Stem Cells (in PDF)
2013-February-5	Novogen Announces Filing of Key Patent Application (in PDF)
2013-February-5	Allocation of Shares to Triaxial Pharmaceutical Shareholders (in PDF)
2015	2015 Press Releases
2014	2014 Press Releases